Your session is about to expire
← Back to Search
Artificial Intelligence
AI-Assisted Colonoscopy for Colorectal Cancer Detection
N/A
Recruiting
Led By James L Buxbaum, MD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up throughout study, an average of 2 years
Awards & highlights
Study Summary
This trial will use AI to measure if it can help improve the accuracy of detecting polyps in colonoscopies, with the potential to reduce colorectal cancer rates.
Who is the study for?
This trial is for Gastroenterology fellows at USC who perform endoscopies. They must agree to participate and give informed consent. Procedures in intensive care or operating rooms, or those done solely by faculty without the fellow as primary operator, are excluded.Check my eligibility
What is being tested?
The study aims to see if using AI during colonoscopy helps trainees find more polyps compared to standard methods without AI. It's a randomized test where some will use AI assistance and others won't, measuring the adenoma detection rate (ADR).See study design
What are the potential side effects?
Since this trial involves comparing different methods of performing endoscopies rather than testing drugs, it doesn't have typical side effects like medications do. However, there may be risks associated with any endoscopic procedure.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ throughout study, an average of 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~throughout study, an average of 2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Average adenoma detection rate
Secondary outcome measures
Average of polyps detection rate
Trial Design
2Treatment groups
Active Control
Group I: Non-Artificial Intelligence Endoscopy RoomActive Control1 Intervention
The fellows will be randomized on a daily basis to perform colonoscopies in a non-AI endoscopy room (standard of care).
Group II: Artificial Intelligence Endoscopy RoomActive Control1 Intervention
The fellows will be randomized on a daily basis to perform colonoscopies in a room with AI (intervention)
Find a Location
Who is running the clinical trial?
University of Southern CaliforniaLead Sponsor
906 Previous Clinical Trials
1,596,151 Total Patients Enrolled
James L Buxbaum, MDPrincipal InvestigatorUniversity of Southern California
4 Previous Clinical Trials
2,682 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My procedure will be in the endoscopy unit, not in intensive care or the operating room.
Research Study Groups:
This trial has the following groups:- Group 1: Non-Artificial Intelligence Endoscopy Room
- Group 2: Artificial Intelligence Endoscopy Room
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still opportunities available to join this experiment?
"According to the online repository of clinical trials, this experiment is actively recruiting participants. It was initially posted on January 1st 2023 and recently edited on March 2nd 2023."
Answered by AI
How many test subjects are being invited to participate in this experiment?
"Indeed, the information on clinicaltrials.gov affirms that this medical trial is presently in search of participants. The study was initially published on January 1st 2023 and has been updated most recently to March 2nd 2023. 25 patients from a single site are required for completion."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger